Clinical Trials · NCT05564117
Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 307
- Start date
- Oct 2022
- Locations
- 23 sites, 4 countries
- Primary endpoint
- Percentage Change in Body Weight